Advertisement

Topics

Albany Molecular Research, Inc. Company Profile

12:50 EDT 18th October 2017 | BioPortfolio

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 22 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in North America, Europe and Asia now provide our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.
AMRI’s services include Contract Research (Discovery), Development and Contract Manufacturing including Aseptic Fill and Finish. Since 1991, AMRI has steadily expanded and globalized its contract services platform beyond its major U.S. facilities through a combination of acquisitions and green field initiatives, which include:

  • process development and large scale manufacturing in the UK;
  • custom library synthesis, medicinal chemistry, chemical development and cGMP scale up and manufacturing in India;
  • medicinal chemistry and in vitro biology in Singapore;
  • aseptic fill and finish capabilities in Burlington, Massachusetts. 

AMRI provides a broad range of services and technologies to provide flexible and strategic support for discovery and development of pharmaceutical products and the manufacturing of API and drug product for existing and experimental new drugs, providing geographic proximity and creative budgetary solutions. 

AMRI is also investing in a small number of discovery programs with the intention to partner promising technology, a high value added service having resulted in five clinical candidates and licensing partnerships with Bristol-Myers Squibb, Genentech and Bessor Pharma.

Location

26 Corporate Circle
Albany
New York
12203
United States of America

Contact

Phone: (518) 512-2000
Fax: (518) 512-2020
Email: info@amriglobal.com


News Articles [681 Associated News Articles listed on BioPortfolio]

GTCR and Carlyle Group are buying Albany Molecular Research for $922 million

Contract drug manufacturer and research company Albany Molecular Research Inc said on Tuesday it agreed to be taken private by buyout firms Carlyle Group LP and GTCR LLC for about $922 million in cash...

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Albany Molecular Research, Inc - AMRI

BALA CYNWYD, PA / ACCESSWIRE / June 9, 2017 / The law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Albany Molecular Research,...

SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of Albany Molecular Research, Inc -AMRI

BALA CYNWYD, PA / ACCESSWIRE / June 15, 2017 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Albany Molecular Research, In...

Carlyle, GTCR to buy Albany Molecular Research for $922m

The Carlyle Group and GTCR have agreed to acquire global contract research and manufacturing organization, Albany Molecular Research (AMRI), for around $922m.

EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Albany Molecular Research, Inc. to The Carlyle Group and GTCR LLC is Fair to Shareholders - AMRI

NEW YORK, NY / ACCESSWIRE / June 20, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Albany Molecular Research, Inc. (NASDAQ: AMRI...

EC nod for acquisition of Albany Molecular Research

The European Commission has approved, under the EU Merger Regulation, the acquisition of joint control…

Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms

Click to view a price quote on AMRI. Click to research the Drugs industry.

PE firms' plan to take AMRI private on track

The Carlyle Group and GTCR LLC are poised to complete the takeover of Albany Molecular Research (AMRI) after the early termination of the mandatory waiting period that covers such deals in the US.

PubMed Articles [2110 Associated PubMed Articles listed on BioPortfolio]

Midwifery continuity of carer in an area of high socio-economic disadvantage in London: A retrospective analysis of Albany Midwifery Practice outcomes using routine data (1997-2009).

in 1997, The Albany Midwifery Practice was established within King's College Hospital NHS Trust in a South East London area of high social disadvantage. The Albany midwives provided continuity of care...

Grant Writing Tips for Translational Research.

All investigators face the same challenge-the highly competitive nature of the grant review process. Innovation alone is not enough to ensure grant-supported funding. Applied clinical research require...

The Molecular Design Research Network: An Overview.

Herein we provide an overview of a research collaborative aimed at fostering interdisciplinary collaboration between chemists and toxicologists with the aim of rationally designing safer commercial ch...

Molecular Biomarkers of Knee Pathology.

The identification of biomarkers has become increasingly important in our fundamental understanding of the molecular basis for disease and subsequently in the advancement of modern medicine. Biomarker...

UPAR targeted molecular imaging of cancers with small molecule-based probes.

Molecular imaging can allow the non-invasive characterization and measurement of biological and biochemical processes at the molecular and cellular levels in living subjects. The imaging of specific m...

Clinical Trials [2048 Associated Clinical Trials listed on BioPortfolio]

Acute Technical Outcomes of the Talent Abdominal Aortic Aneurysm (AAA) Stent-Graft Versus Cook Zenith Stent-Graft

The purpose of this study is to compare acute technical outcomes of the Talent AAA Stent Graft system versus Cook Zenith Endograft at two high volume institutions, Albany Medical Center an...

Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas

The aim of the planned research project is to find out the clinical significance of molecular genetic analyzes in gynecological malignomas. In particular, it will be investigated how the k...

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of Non-Small Cell Lung Carcinoma Patients

Open, non-interventional, prospective, multi-center clinical research platform with the main objective to assess molecular biomarker testing, treatment and outcome of patients with advance...

Biopsies of Cancer Patients for Tumor Molecular Characterization

In this research study, we are looking at performing a repeat biopsy of patients' tumors, even though they have already been diagnosed with cancer. The tumor tissue obtained from the biop...

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.

Companies [1890 Associated Companies listed on BioPortfolio]

Albany Molecular Research Incorporated

Founded in 1991, Albany Molecular Research, Inc. is a chemistry company with a core nucleus of accomplished scientists who have extensive experience within the pharmaceutical industry. Albany Molecula...

Albany Molecular Research, Inc.

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For o...

Albany Molecular Research, Inc. (AMRI)

Albany College of Pharmacy and Health Sciences

Founded in 1881, Albany College of Pharmacy and Health Sciences is a private, independent institution committed to the advancement of health. The College has academic programs and research activities ...

Eagle Pharmaceuticals Inc. and Albany Molecular Research Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists a...

More Information about "Albany Molecular Research, Inc." on BioPortfolio

We have published hundreds of Albany Molecular Research, Inc. news stories on BioPortfolio along with dozens of Albany Molecular Research, Inc. Clinical Trials and PubMed Articles about Albany Molecular Research, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Albany Molecular Research, Inc. Companies in our database. You can also find out about relevant Albany Molecular Research, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record